DongKoo Bio has obtained a number of drugs that are the same as the new diabetes drug "Dapagliflozin+Sitagliptin" approved on the 23rd of last month. A large number of consignment items produced by Dongkoo Bio have entered. Dapagliflozin+Sitaglipin is a new combination complex that has never been released before, but competition has become inevitable as many pharmaceutical companies have secured it even before its launch.

On the 4th, the MFDS approved 22 items combined with Dapagliflozin+Sitaglipin. Licensed pharmaceutical companies are Aprogen, Aju, PharmGen Science , NBK Pharm, Jin Yang, Dae Hwa, Myung Moon, GC Pharma, Dongkwang, Lite pharm tech, Binex, SCD Pharm, Daewoo, Kukje, Shinpoong, Ilyang, Re